FdaApplication
ANDA 214219
Identifiers
- fda_app_no: ANDA214219
Properties
| Property | Value |
|---|---|
| applicant_name | INGENUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2020-10-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRIAZOLAM | TRIAZOLAM | 0.125MG | TABLET;ORAL |
| TRIAZOLAM | TRIAZOLAM | 0.25MG | TABLET;ORAL |
2 products